Measuring quality of life in women with endometriosis: tests of data quality, score reliability, response rate and scaling assumptions of the Endometriosis Health Profile Questionnaire
This study validated the Endometriosis Health Profile-30 questionnaire, confirming its factor structure and scoring assumptions, and demonstrating high data completeness and reliability for measuring quality of life in women with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Outcome instruments
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (32)
- A health-related quality-of-life instrument for symptomatic patients with endometriosis: A validation study via openalex
- A psychological profile of endometriosis patients in comparison to patients with pelvic pain of other origins via openalex
- Endometriosis via openalex
- Endometriosis : current understanding and management via openalex
- Evaluating the responsiveness of the endometriosis health profile questionnaire: The EHP-30 via openalex
- Is There a Genetic Basis to Endometriosis? via openalex
- Measuring health-related quality of life outcomes in women with endometriosis--results of the Gynaecology Audit Project in Scotland. via openalex
- Psychosocial aspects of endometriosis: A review via openalex
- W2022581863 via openalex
- W2029000009 via openalex
- W2030038103 via openalex
- W2034164005 via openalex
- W2037377025 via openalex
- W2039703741 via openalex
- W2066002297 via openalex
- W2080000533 via openalex
- W2081226710 via openalex
- W2083953255 via openalex
- W2091842258 via openalex
- W2125070112 via openalex
- W2125272611 via openalex
- W2159306398 via openalex
- W2244972437 via openalex
- W2798523851 via openalex
- W4285719527 via openalex
- W1506603089 via openalex
- W1586047194 via openalex
- W1980015741 via openalex
- W1987604705 via openalex
- W1996855651 via openalex
- W2001906671 via openalex
- W2019398887 via openalex
Cited by (50)
- Effect of mindful breathing on anxiety, depression, and quality of life among women with endometriosis 2026
- Chemokines and Their Association With Symptom Severity in Women With Endometriosis 2025
- Dichloroacetate for the treatment of endometriosis-associated pain (EPiC1): a single-arm feasibility study 2025
- Influence of endometrial nerve fibers and hormones on pain in women with endometriosis 2025
- Evaluation of the Effect of Dietary Habits on the Health Profile in Women with Endometriosis 2025
- Directive clinique no 449 : Directive canadienne sur le diagnostic et les impacts de l’endométriose 2024
- Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial 2024
- Measurement of changes to the menstrual cycle: A transdisciplinary systematic review evaluating measure quality and utility for clinical trials 2024
- Guideline No. 449: Diagnosis and Impact of Endometriosis – A Canadian Guideline 2024
- IVF stimulation protocols and outcomes in women with endometriosis 2023
- The psychometric properties test of the Malay version of the endometriosis health profile-30 2023
- Long‐term effects of surgically corrected menstrual outflow obstruction: A case–control study 2023
- Clinical factors associated with quality of life among women with endometriosis: a cross-sectional study 2023
- Association of Dysmenorrhea with Endometriosis: a Literature Review 2023
- Pelvic pain comorbidities associated with quality of life after endometriosis surgery 2023
- Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment? 2023
- Establishing the Australian National Endometriosis Clinical and Scientific Trials (NECST) Registry: a protocol paper 2023
- An Evaluation of the Effect of Lifestyle on the Incidence of Endometriosis 2023
- A systematic review to determine use of the Endometriosis Health Profiles to measure quality of life outcomes in women with endometriosis 2023
- Unified Protocol for Endometriosis 2023
- Health-related quality of life in endometriosis: The influence of endometriosis-related symptom presence and distress 2022
- Impact of Long-Term Dienogest Therapy on Quality of Life in Asian Women with Endometriosis: the Prospective Non-Interventional Study ENVISIOeN 2022
- Psychosocial correlates of symptoms of depression among patients with endometriosis in the United Kingdom 2022
- Body image and depression in endometriosis: Examining self-esteem and rumination as mediators 2022
- Assessing the experience of dyspareunia in the endometriosis population: the Subjective Impact of Dyspareunia Inventory (SIDI) 2022
- Additional file 4 of Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results 2021
- Health-related quality of life in women with endometriosis: psychometric validation of the Endometriosis Health Profile 30 questionnaire using confirmatory factor analysis 2021
- Additional file 5 of Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results 2021
- Additional file 2 of Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results 2021
- Additional file 1 of Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results 2021
- Additional file 3 of Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results 2021
- Pelvic pain correlates with peritoneal macrophage abundance not endometriosis 2021
- Effectiveness of intracavitary monopolar dielectric radiofrequency in women with endometriosis-associated pain: A case series 2021
- Effect of hysterectomy on pain in women with endometriosis: a population‐based registry study 2020
- Reduction of endometriosis-related pain: efficacy of trace elements in a double-blind, randomized, placebo-controlled trial 2020
- Peritoneal macrophage phenotype correlates with pain scores in women with suspected endometriosis 2020
- Elagolix in the treatment of endometriosis: impact beyond pain symptoms 2020
- Quality of life assessment and screening tool development for endometriosis 2020
- Psychometric evaluation of the Swedish version of the 30-item endometriosis health profile (EHP-30) 2020
- Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose–response manner: a randomized, double-blind, placebo-controlled study 2020
- Cross-Sectional Survey of the Impact of Endometriosis Symptoms on Health-Related Quality of Life in Canadian Women 2020
- Quality of life in women with endometriosis: a narrative overview 2020
- The Impact of Female Chronic Pelvic Pain Questionnaire (IF-CPPQ) 2019
- Long-term evaluation of quality of life and gastrointestinal well-being after segmental colo-rectal resection for deep infiltrating endometriosis (ENDO-RESECT QoL) 2019
- Systematic review of quality of life measures in patients with endometriosis 2019
- Evaluation, validation and refinement of noninvasive diagnostic biomarkers for endometriosis (ENDOmarker): A protocol to phenotype bio-specimens for discovery and validation 2018
- Impact of coping strategies on quality of life of adolescents and young women with endometriosis 2018
- Are symptoms after a colorectal segmental resection in deep endometriosis really improved? The point of view of women before and after surgery 2018
- Development and content validation of a patient-reported endometriosis pain daily diary 2018
- Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique®) in the treatment of endometriosis symptoms: A prospective open-label comparative study 2018
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:15:18.313808+00:00